Global Biotherapeutics Cell Line Development Market Research Report 2023

Publisher Name :
Date: 16-Mar-2023
No. of pages: 85
Inquire Before Buying

Highlights

The global Biotherapeutics Cell Line Development market was valued at US$ 58250 million in 2022 and is anticipated to reach US$ 75420 million by 2029, witnessing a CAGR of 4.4% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Biotherapeutics Cell Line Development is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Biotherapeutics Cell Line Development is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global market for Biotherapeutics Cell Line Development in In-house is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global companies of Biotherapeutics Cell Line Development include Becton Dickinson & Company, Beckman Coulter, Boehringer Ingelheim Group, Catalent Inc., CMC Biologics A/S, Lonza Group Ltd., EMD Millipore, Partec (Sysmex Corporation) and ProBioGen AG, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biotherapeutics Cell Line Development, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biotherapeutics Cell Line Development.

The Biotherapeutics Cell Line Development market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Biotherapeutics Cell Line Development market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biotherapeutics Cell Line Development companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

By Company

- Becton Dickinson & Company

- Beckman Coulter

- Boehringer Ingelheim Group

- Catalent Inc.

- CMC Biologics A/S

- Lonza Group Ltd.

- EMD Millipore

- Partec (Sysmex Corporation)

- ProBioGen AG

- Selexis SA

- Sigma-Aldrich Co. LLC.

- Sony Biotechnology Inc.

- Thermo Fisher Scientific Inc.

Segment by Type

- Transfection & Selection

- Single Cell Cloning

Segment by Application

- In-house

- Outsource

- Hybrid

- Do-It-Yourself (DIY)

By Region

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- - Nordic Countries

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Biotherapeutics Cell Line Development companies' competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Global Biotherapeutics Cell Line Development Market Research Report 2023

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biotherapeutics Cell Line Development Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Transfection & Selection
1.2.3 Single Cell Cloning
1.3 Market by Application
1.3.1 Global Biotherapeutics Cell Line Development Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 In-house
1.3.3 Outsource
1.3.4 Hybrid
1.3.5 Do-It-Yourself (DIY)
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biotherapeutics Cell Line Development Market Perspective (2018-2029)
2.2 Biotherapeutics Cell Line Development Growth Trends by Region
2.2.1 Global Biotherapeutics Cell Line Development Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Biotherapeutics Cell Line Development Historic Market Size by Region (2018-2023)
2.2.3 Biotherapeutics Cell Line Development Forecasted Market Size by Region (2024-2029)
2.3 Biotherapeutics Cell Line Development Market Dynamics
2.3.1 Biotherapeutics Cell Line Development Industry Trends
2.3.2 Biotherapeutics Cell Line Development Market Drivers
2.3.3 Biotherapeutics Cell Line Development Market Challenges
2.3.4 Biotherapeutics Cell Line Development Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biotherapeutics Cell Line Development Players by Revenue
3.1.1 Global Top Biotherapeutics Cell Line Development Players by Revenue (2018-2023)
3.1.2 Global Biotherapeutics Cell Line Development Revenue Market Share by Players (2018-2023)
3.2 Global Biotherapeutics Cell Line Development Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biotherapeutics Cell Line Development Revenue
3.4 Global Biotherapeutics Cell Line Development Market Concentration Ratio
3.4.1 Global Biotherapeutics Cell Line Development Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biotherapeutics Cell Line Development Revenue in 2022
3.5 Biotherapeutics Cell Line Development Key Players Head office and Area Served
3.6 Key Players Biotherapeutics Cell Line Development Product Solution and Service
3.7 Date of Enter into Biotherapeutics Cell Line Development Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biotherapeutics Cell Line Development Breakdown Data by Type
4.1 Global Biotherapeutics Cell Line Development Historic Market Size by Type (2018-2023)
4.2 Global Biotherapeutics Cell Line Development Forecasted Market Size by Type (2024-2029)
5 Biotherapeutics Cell Line Development Breakdown Data by Application
5.1 Global Biotherapeutics Cell Line Development Historic Market Size by Application (2018-2023)
5.2 Global Biotherapeutics Cell Line Development Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Biotherapeutics Cell Line Development Market Size (2018-2029)
6.2 North America Biotherapeutics Cell Line Development Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Biotherapeutics Cell Line Development Market Size by Country (2018-2023)
6.4 North America Biotherapeutics Cell Line Development Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biotherapeutics Cell Line Development Market Size (2018-2029)
7.2 Europe Biotherapeutics Cell Line Development Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Biotherapeutics Cell Line Development Market Size by Country (2018-2023)
7.4 Europe Biotherapeutics Cell Line Development Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biotherapeutics Cell Line Development Market Size (2018-2029)
8.2 Asia-Pacific Biotherapeutics Cell Line Development Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Biotherapeutics Cell Line Development Market Size by Region (2018-2023)
8.4 Asia-Pacific Biotherapeutics Cell Line Development Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biotherapeutics Cell Line Development Market Size (2018-2029)
9.2 Latin America Biotherapeutics Cell Line Development Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Biotherapeutics Cell Line Development Market Size by Country (2018-2023)
9.4 Latin America Biotherapeutics Cell Line Development Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biotherapeutics Cell Line Development Market Size (2018-2029)
10.2 Middle East & Africa Biotherapeutics Cell Line Development Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Biotherapeutics Cell Line Development Market Size by Country (2018-2023)
10.4 Middle East & Africa Biotherapeutics Cell Line Development Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Becton Dickinson & Company
11.1.1 Becton Dickinson & Company Company Detail
11.1.2 Becton Dickinson & Company Business Overview
11.1.3 Becton Dickinson & Company Biotherapeutics Cell Line Development Introduction
11.1.4 Becton Dickinson & Company Revenue in Biotherapeutics Cell Line Development Business (2018-2023)
11.1.5 Becton Dickinson & Company Recent Development
11.2 Beckman Coulter
11.2.1 Beckman Coulter Company Detail
11.2.2 Beckman Coulter Business Overview
11.2.3 Beckman Coulter Biotherapeutics Cell Line Development Introduction
11.2.4 Beckman Coulter Revenue in Biotherapeutics Cell Line Development Business (2018-2023)
11.2.5 Beckman Coulter Recent Development
11.3 Boehringer Ingelheim Group
11.3.1 Boehringer Ingelheim Group Company Detail
11.3.2 Boehringer Ingelheim Group Business Overview
11.3.3 Boehringer Ingelheim Group Biotherapeutics Cell Line Development Introduction
11.3.4 Boehringer Ingelheim Group Revenue in Biotherapeutics Cell Line Development Business (2018-2023)
11.3.5 Boehringer Ingelheim Group Recent Development
11.4 Catalent Inc.
11.4.1 Catalent Inc. Company Detail
11.4.2 Catalent Inc. Business Overview
11.4.3 Catalent Inc. Biotherapeutics Cell Line Development Introduction
11.4.4 Catalent Inc. Revenue in Biotherapeutics Cell Line Development Business (2018-2023)
11.4.5 Catalent Inc. Recent Development
11.5 CMC Biologics A/S
11.5.1 CMC Biologics A/S Company Detail
11.5.2 CMC Biologics A/S Business Overview
11.5.3 CMC Biologics A/S Biotherapeutics Cell Line Development Introduction
11.5.4 CMC Biologics A/S Revenue in Biotherapeutics Cell Line Development Business (2018-2023)
11.5.5 CMC Biologics A/S Recent Development
11.6 Lonza Group Ltd.
11.6.1 Lonza Group Ltd. Company Detail
11.6.2 Lonza Group Ltd. Business Overview
11.6.3 Lonza Group Ltd. Biotherapeutics Cell Line Development Introduction
11.6.4 Lonza Group Ltd. Revenue in Biotherapeutics Cell Line Development Business (2018-2023)
11.6.5 Lonza Group Ltd. Recent Development
11.7 EMD Millipore
11.7.1 EMD Millipore Company Detail
11.7.2 EMD Millipore Business Overview
11.7.3 EMD Millipore Biotherapeutics Cell Line Development Introduction
11.7.4 EMD Millipore Revenue in Biotherapeutics Cell Line Development Business (2018-2023)
11.7.5 EMD Millipore Recent Development
11.8 Partec (Sysmex Corporation)
11.8.1 Partec (Sysmex Corporation) Company Detail
11.8.2 Partec (Sysmex Corporation) Business Overview
11.8.3 Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Introduction
11.8.4 Partec (Sysmex Corporation) Revenue in Biotherapeutics Cell Line Development Business (2018-2023)
11.8.5 Partec (Sysmex Corporation) Recent Development
11.9 ProBioGen AG
11.9.1 ProBioGen AG Company Detail
11.9.2 ProBioGen AG Business Overview
11.9.3 ProBioGen AG Biotherapeutics Cell Line Development Introduction
11.9.4 ProBioGen AG Revenue in Biotherapeutics Cell Line Development Business (2018-2023)
11.9.5 ProBioGen AG Recent Development
11.10 Selexis SA
11.10.1 Selexis SA Company Detail
11.10.2 Selexis SA Business Overview
11.10.3 Selexis SA Biotherapeutics Cell Line Development Introduction
11.10.4 Selexis SA Revenue in Biotherapeutics Cell Line Development Business (2018-2023)
11.10.5 Selexis SA Recent Development
11.11 Sigma-Aldrich Co. LLC.
11.11.1 Sigma-Aldrich Co. LLC. Company Detail
11.11.2 Sigma-Aldrich Co. LLC. Business Overview
11.11.3 Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Introduction
11.11.4 Sigma-Aldrich Co. LLC. Revenue in Biotherapeutics Cell Line Development Business (2018-2023)
11.11.5 Sigma-Aldrich Co. LLC. Recent Development
11.12 Sony Biotechnology Inc.
11.12.1 Sony Biotechnology Inc. Company Detail
11.12.2 Sony Biotechnology Inc. Business Overview
11.12.3 Sony Biotechnology Inc. Biotherapeutics Cell Line Development Introduction
11.12.4 Sony Biotechnology Inc. Revenue in Biotherapeutics Cell Line Development Business (2018-2023)
11.12.5 Sony Biotechnology Inc. Recent Development
11.13 Thermo Fisher Scientific Inc.
11.13.1 Thermo Fisher Scientific Inc. Company Detail
11.13.2 Thermo Fisher Scientific Inc. Business Overview
11.13.3 Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Introduction
11.13.4 Thermo Fisher Scientific Inc. Revenue in Biotherapeutics Cell Line Development Business (2018-2023)
11.13.5 Thermo Fisher Scientific Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Biotherapeutics Cell Line Development Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Transfection & Selection
Table 3. Key Players of Single Cell Cloning
Table 4. Global Biotherapeutics Cell Line Development Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Biotherapeutics Cell Line Development Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Biotherapeutics Cell Line Development Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Biotherapeutics Cell Line Development Market Share by Region (2018-2023)
Table 8. Global Biotherapeutics Cell Line Development Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Biotherapeutics Cell Line Development Market Share by Region (2024-2029)
Table 10. Biotherapeutics Cell Line Development Market Trends
Table 11. Biotherapeutics Cell Line Development Market Drivers
Table 12. Biotherapeutics Cell Line Development Market Challenges
Table 13. Biotherapeutics Cell Line Development Market Restraints
Table 14. Global Biotherapeutics Cell Line Development Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Biotherapeutics Cell Line Development Market Share by Players (2018-2023)
Table 16. Global Top Biotherapeutics Cell Line Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biotherapeutics Cell Line Development as of 2022)
Table 17. Ranking of Global Top Biotherapeutics Cell Line Development Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Biotherapeutics Cell Line Development Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Biotherapeutics Cell Line Development Product Solution and Service
Table 21. Date of Enter into Biotherapeutics Cell Line Development Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Biotherapeutics Cell Line Development Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Biotherapeutics Cell Line Development Revenue Market Share by Type (2018-2023)
Table 25. Global Biotherapeutics Cell Line Development Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Biotherapeutics Cell Line Development Revenue Market Share by Type (2024-2029)
Table 27. Global Biotherapeutics Cell Line Development Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Biotherapeutics Cell Line Development Revenue Market Share by Application (2018-2023)
Table 29. Global Biotherapeutics Cell Line Development Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Biotherapeutics Cell Line Development Revenue Market Share by Application (2024-2029)
Table 31. North America Biotherapeutics Cell Line Development Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Biotherapeutics Cell Line Development Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Biotherapeutics Cell Line Development Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Biotherapeutics Cell Line Development Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Biotherapeutics Cell Line Development Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Biotherapeutics Cell Line Development Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Biotherapeutics Cell Line Development Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Biotherapeutics Cell Line Development Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Biotherapeutics Cell Line Development Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Biotherapeutics Cell Line Development Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Biotherapeutics Cell Line Development Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Biotherapeutics Cell Line Development Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Biotherapeutics Cell Line Development Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Biotherapeutics Cell Line Development Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Biotherapeutics Cell Line Development Market Size by Country (2024-2029) & (US$ Million)
Table 46. Becton Dickinson & Company Company Detail
Table 47. Becton Dickinson & Company Business Overview
Table 48. Becton Dickinson & Company Biotherapeutics Cell Line Development Product
Table 49. Becton Dickinson & Company Revenue in Biotherapeutics Cell Line Development Business (2018-2023) & (US$ Million)
Table 50. Becton Dickinson & Company Recent Development
Table 51. Beckman Coulter Company Detail
Table 52. Beckman Coulter Business Overview
Table 53. Beckman Coulter Biotherapeutics Cell Line Development Product
Table 54. Beckman Coulter Revenue in Biotherapeutics Cell Line Development Business (2018-2023) & (US$ Million)
Table 55. Beckman Coulter Recent Development
Table 56. Boehringer Ingelheim Group Company Detail
Table 57. Boehringer Ingelheim Group Business Overview
Table 58. Boehringer Ingelheim Group Biotherapeutics Cell Line Development Product
Table 59. Boehringer Ingelheim Group Revenue in Biotherapeutics Cell Line Development Business (2018-2023) & (US$ Million)
Table 60. Boehringer Ingelheim Group Recent Development
Table 61. Catalent Inc. Company Detail
Table 62. Catalent Inc. Business Overview
Table 63. Catalent Inc. Biotherapeutics Cell Line Development Product
Table 64. Catalent Inc. Revenue in Biotherapeutics Cell Line Development Business (2018-2023) & (US$ Million)
Table 65. Catalent Inc. Recent Development
Table 66. CMC Biologics A/S Company Detail
Table 67. CMC Biologics A/S Business Overview
Table 68. CMC Biologics A/S Biotherapeutics Cell Line Development Product
Table 69. CMC Biologics A/S Revenue in Biotherapeutics Cell Line Development Business (2018-2023) & (US$ Million)
Table 70. CMC Biologics A/S Recent Development
Table 71. Lonza Group Ltd. Company Detail
Table 72. Lonza Group Ltd. Business Overview
Table 73. Lonza Group Ltd. Biotherapeutics Cell Line Development Product
Table 74. Lonza Group Ltd. Revenue in Biotherapeutics Cell Line Development Business (2018-2023) & (US$ Million)
Table 75. Lonza Group Ltd. Recent Development
Table 76. EMD Millipore Company Detail
Table 77. EMD Millipore Business Overview
Table 78. EMD Millipore Biotherapeutics Cell Line Development Product
Table 79. EMD Millipore Revenue in Biotherapeutics Cell Line Development Business (2018-2023) & (US$ Million)
Table 80. EMD Millipore Recent Development
Table 81. Partec (Sysmex Corporation) Company Detail
Table 82. Partec (Sysmex Corporation) Business Overview
Table 83. Partec (Sysmex Corporation) Biotherapeutics Cell Line Development Product
Table 84. Partec (Sysmex Corporation) Revenue in Biotherapeutics Cell Line Development Business (2018-2023) & (US$ Million)
Table 85. Partec (Sysmex Corporation) Recent Development
Table 86. ProBioGen AG Company Detail
Table 87. ProBioGen AG Business Overview
Table 88. ProBioGen AG Biotherapeutics Cell Line Development Product
Table 89. ProBioGen AG Revenue in Biotherapeutics Cell Line Development Business (2018-2023) & (US$ Million)
Table 90. ProBioGen AG Recent Development
Table 91. Selexis SA Company Detail
Table 92. Selexis SA Business Overview
Table 93. Selexis SA Biotherapeutics Cell Line Development Product
Table 94. Selexis SA Revenue in Biotherapeutics Cell Line Development Business (2018-2023) & (US$ Million)
Table 95. Selexis SA Recent Development
Table 96. Sigma-Aldrich Co. LLC. Company Detail
Table 97. Sigma-Aldrich Co. LLC. Business Overview
Table 98. Sigma-Aldrich Co. LLC. Biotherapeutics Cell Line Development Product
Table 99. Sigma-Aldrich Co. LLC. Revenue in Biotherapeutics Cell Line Development Business (2018-2023) & (US$ Million)
Table 100. Sigma-Aldrich Co. LLC. Recent Development
Table 101. Sony Biotechnology Inc. Company Detail
Table 102. Sony Biotechnology Inc. Business Overview
Table 103. Sony Biotechnology Inc. Biotherapeutics Cell Line Development Product
Table 104. Sony Biotechnology Inc. Revenue in Biotherapeutics Cell Line Development Business (2018-2023) & (US$ Million)
Table 105. Sony Biotechnology Inc. Recent Development
Table 106. Thermo Fisher Scientific Inc. Company Detail
Table 107. Thermo Fisher Scientific Inc. Business Overview
Table 108. Thermo Fisher Scientific Inc. Biotherapeutics Cell Line Development Product
Table 109. Thermo Fisher Scientific Inc. Revenue in Biotherapeutics Cell Line Development Business (2018-2023) & (US$ Million)
Table 110. Thermo Fisher Scientific Inc. Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biotherapeutics Cell Line Development Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Biotherapeutics Cell Line Development Market Share by Type: 2022 VS 2029
Figure 3. Transfection & Selection Features
Figure 4. Single Cell Cloning Features
Figure 5. Global Biotherapeutics Cell Line Development Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Biotherapeutics Cell Line Development Market Share by Application: 2022 VS 2029
Figure 7. In-house Case Studies
Figure 8. Outsource Case Studies
Figure 9. Hybrid Case Studies
Figure 10. Do-It-Yourself (DIY) Case Studies
Figure 11. Biotherapeutics Cell Line Development Report Years Considered
Figure 12. Global Biotherapeutics Cell Line Development Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 13. Global Biotherapeutics Cell Line Development Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 14. Global Biotherapeutics Cell Line Development Market Share by Region: 2022 VS 2029
Figure 15. Global Biotherapeutics Cell Line Development Market Share by Players in 2022
Figure 16. Global Top Biotherapeutics Cell Line Development Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biotherapeutics Cell Line Development as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Biotherapeutics Cell Line Development Revenue in 2022
Figure 18. North America Biotherapeutics Cell Line Development Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. North America Biotherapeutics Cell Line Development Market Share by Country (2018-2029)
Figure 20. United States Biotherapeutics Cell Line Development Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Biotherapeutics Cell Line Development Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Biotherapeutics Cell Line Development Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Biotherapeutics Cell Line Development Market Share by Country (2018-2029)
Figure 24. Germany Biotherapeutics Cell Line Development Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. France Biotherapeutics Cell Line Development Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. U.K. Biotherapeutics Cell Line Development Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Italy Biotherapeutics Cell Line Development Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Russia Biotherapeutics Cell Line Development Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Nordic Countries Biotherapeutics Cell Line Development Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Biotherapeutics Cell Line Development Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Asia-Pacific Biotherapeutics Cell Line Development Market Share by Region (2018-2029)
Figure 32. China Biotherapeutics Cell Line Development Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Japan Biotherapeutics Cell Line Development Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. South Korea Biotherapeutics Cell Line Development Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Southeast Asia Biotherapeutics Cell Line Development Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. India Biotherapeutics Cell Line Development Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Australia Biotherapeutics Cell Line Development Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Biotherapeutics Cell Line Development Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Latin America Biotherapeutics Cell Line Development Market Share by Country (2018-2029)
Figure 40. Mexico Biotherapeutics Cell Line Development Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Brazil Biotherapeutics Cell Line Development Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Biotherapeutics Cell Line Development Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Middle East & Africa Biotherapeutics Cell Line Development Market Share by Country (2018-2029)
Figure 44. Turkey Biotherapeutics Cell Line Development Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Saudi Arabia Biotherapeutics Cell Line Development Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Becton Dickinson & Company Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2018-2023)
Figure 47. Beckman Coulter Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2018-2023)
Figure 48. Boehringer Ingelheim Group Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2018-2023)
Figure 49. Catalent Inc. Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2018-2023)
Figure 50. CMC Biologics A/S Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2018-2023)
Figure 51. Lonza Group Ltd. Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2018-2023)
Figure 52. EMD Millipore Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2018-2023)
Figure 53. Partec (Sysmex Corporation) Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2018-2023)
Figure 54. ProBioGen AG Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2018-2023)
Figure 55. Selexis SA Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2018-2023)
Figure 56. Sigma-Aldrich Co. LLC. Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2018-2023)
Figure 57. Sony Biotechnology Inc. Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2018-2023)
Figure 58. Thermo Fisher Scientific Inc. Revenue Growth Rate in Biotherapeutics Cell Line Development Business (2018-2023)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
  • Global Scaffold Free 3D Cell Culture Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 98
    According to our LPI (LP Information) latest study, the global Scaffold Free 3D Cell Culture market size was valued at US$ 35 million in 2023. With growing demand in downstream market, the Scaffold Free 3D Cell Culture is forecast to a readjusted size of US$ 88 million by 2030 with a CAGR of 14.0% during review period. The research report highlights the growth potential of the global Scaffold Free 3D Cell Culture market. Scaffold Free 3D Cell Culture are expected to show stable growth in......
  • Global Cell Culture Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 115
    According to our LPI (LP Information) latest study, the global Cell Culture market size was valued at US$ 1266.6 million in 2023. With growing demand in downstream market, the Cell Culture is forecast to a readjusted size of US$ 1959.5 million by 2030 with a CAGR of 6.4% during review period. The research report highlights the growth potential of the global Cell Culture market. Cell Culture are expected to show stable growth in the future market. However, product differentiation, reducin......
  • Global Fetal Bovine Serum Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 160
    According to our LPI (LP Information) latest study, the global Fetal Bovine Serum market size was valued at US$ 947.8 million in 2023. With growing demand in downstream market, the Fetal Bovine Serum is forecast to a readjusted size of US$ 1003.6 million by 2030 with a CAGR of 0.8% during review period. The research report highlights the growth potential of the global Fetal Bovine Serum market. Fetal Bovine Serum are expected to show stable growth in the future market. However, product d......
  • Global 3D Cell Culture Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 135
    According to our LPI (LP Information) latest study, the global 3D Cell Culture market size was valued at US$ 398.5 million in 2023. With growing demand in downstream market, the 3D Cell Culture is forecast to a readjusted size of US$ 924.1 million by 2030 with a CAGR of 12.8% during review period. The research report highlights the growth potential of the global 3D Cell Culture market. 3D Cell Culture are expected to show stable growth in the future market. However, product differentiati......
  • Global 3D Cell Culture Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 138
    According to our (Global Info Research) latest study, the global 3D Cell Culture market size was valued at USD 419.1 million in 2023 and is forecast to a readjusted size of USD 913.9 million by 2030 with a CAGR of 11.8% during review period. A 3D cell culture is an artificially-created environment in which biological cells are permitted to grow or interact with their surroundings in all three dimensions. Unlike 2D environments (e.g. a petri dish), a 3D cell culture allows cells in vitro ......
  • Global Fetal Bovine Serum Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 150
    According to our (Global Info Research) latest study, the global Fetal Bovine Serum market size was valued at USD 997 million in 2023 and is forecast to a readjusted size of USD 1050.9 million by 2030 with a CAGR of 0.8% during review period. Fetal bovine serum (FBS) is the liquid fraction of clotted blood from fetal calves, depleted of cells, fibrin and clotting factors, but containing a large number of nutritional and macromolecular factors essential for cell growth. Bovine serum album......
  • Global Scaffold Free 3D Cell Culture Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 99
    Market Overview of Global Scaffold Free 3D Cell Culture market: According to our latest research, the global Scaffold Free 3D Cell Culture market looks promising in the next 5 years. As of 2022, the global Scaffold Free 3D Cell Culture market was estimated at USD 37.31 million, and it's anticipated to reach USD 94.67 million in 2028, with a CAGR of 16.79% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensiv......
  • Global 3D Cell Culture Market Research Report 2024 (Status and Outlook)
    Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 132
    Report Overview: A 3D cell culture is an artificially-created environment in which biological cells are permitted to grow or interact with their surroundings in all three dimensions. Unlike 2D environments (e.g. a petri dish), a 3D cell culture allows cells in vitro to grow in all directions, similar to how they would in vivo. These three-dimensional cultures are usually grown in bioreactors, small capsules in which the cells can grow into spheroids, or 3D cell colonies. Approximately 300 ......
  • Global Cell Line Development Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 14-Dec-2023        Price: US 3380 Onwards        Pages: 118
    Market Overview of Global Cell Line Development market: According to our latest research, the global Cell Line Development market looks promising in the next 5 years. As of 2022, the global Cell Line Development market was estimated at USD 3709.62 million, and it's anticipated to reach USD 7485.53 million in 2028, with a CAGR of 12.41% during the forecast years. Cell lines are essential for a wide range of applications including gene function studies, drug discovery assays, t......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs